1,8-Dichlorooctane

We are 1,8-Dichlorooctane CAS:2162-99-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1,8-Dichlorooctane
CAS.NO:2162-99-4
Synonyms:1,8-Dichlorooctane
1,8-dichloro-octane
Octamethylene Chloride
Octane,1,8-dichloro
Octamethylenchlorid
Octane, 1,8-dichloro-
Molecular Formula:C8H16Cl2
Molecular Weight:183.11900
 
Physical and Chemical Properties:
Density:1.025
Melting point:-8ºC
Boiling point:115-116ºC
Flash point:228°F
Index of Refraction:115-116
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

1,8-Dichlorooctane


Related News: The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.2-cloro-N- (2,6-dietilfenil) acetamida CAS:6967-29-9 Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.Dimetil (2-oxo-4-fenilbutil) fosfonato CAS:41162-19-0 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate CAS:132335-47-8 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.API and raw material are often confused due to the similar usage of the two terms.

Related Products
Product Name
4-Chloro-2-methylbenzonitrile View Details
6-chloro-4-iodopyridin-3-ol View Details
(S)-tert-Butyl (4-chloro-3-oxo-1-phenylbutan-2-yl)carbamate View Details
2,6-Dichloroquinoxaline manufacturer 2-Benzoxazolinone manufacturer 5′-Tosyl Adenosine manufacturer 2-Chloro-4,6-diphenylpyrimidine manufacturer 3-Chloro-4-fluorobenzonitrile manufacturer